Evidence map›Paper›PMID 39582366›Full record

ArticleJournal of cosmetic dermatology2025

Mesenchymal Stem Cell Exosomes Therapy for Acquired Trichorrhexis Nodosa: A Case Series.

Xi Chen, Jing Pang, Jianke Li, Xiuhuan Wang, Zihao Mi, Zhenbo Hu, Guoyan Liu

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xi ChenHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.ORCID https://orcid.org/0009-0001-9774-2742
Jing PangHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Jianke LiHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Xiuhuan WangHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Zihao MiHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Zhenbo HuLaboratory for Stem Cell and Regenerative Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.
Guoyan LiuHospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.

Funding

Medical and Health Science and Technology Development Project of Shandong Province 202320001415Natural Science Foundation of Shandong Province ZR2023MH046
6 · The paper itself

Abstract

backgroundRecent preclinical studies have demonstrated the potential efficacy of stem cell exosomes in the treatment of hair loss. However, there is a paucity of clinical studies investigating the application of exosomes for this purpose. This case series presents three patients treated with exosomes for acquired trichorrhexis nodosa (ATN), a condition characterized by hair shaft abnormalities and breakage.

objectivesThis study aims to evaluate the effectiveness and safety of utilizing mesenchymal stem cell (MSC) exosomes as a novel therapeutic approach for the management of ATN.

methodsA standardized process was employed to prepare 0.1 mL of exosomes, which were subsequently injected into bilateral regions of the patients' scalps at 0.5-1 cm intervals on a monthly basis. Each injection comprised a total volume of 5 mL, and all three patients underwent a minimum of four treatment sessions. The comparative efficacy of the treatment was evaluated using clinical photographs, dermatoscopy, and scanning electron microscopy (SEM) for all three patients post-intervention.

resultsThe hair condition of the three patients demonstrated significant improvement, characterized by increased length and density, enhanced pigmentation with a reduced presence of dusty white dots, and the disappearance of dermoscopic black dots and broken hairs. SEM analysis revealed a remarkable recovery in the hair cuticle layers. At the 1-year follow-up, hair growth essentially remained normal.

conclusionExosomes derived from mesenchymal stem cells demonstrate efficacy in treating ATN, presenting a novel therapeutic approach for this condition.

Indexed as

ExosomesHair DiseasesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationAdultDermoscopyFemaleHairHumansMaleMicroscopy, Electron, ScanningMiddle AgedScalpTreatment Outcomeacquiredexosomeshair shaft disordertrichorrhexis nodosa

Identifiers

PMID39582366
PMCPMC11845962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.